Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Call for Investment in Sponsorship, Apprenticeship, and Mentorship: Ensuring the Future of Congenital Heart Surgery.

The Annals of thoracic surgery·2026

Same author

Single Ventricle Physiology May Not Preclude Cardiac Repair in the Setting of Congenital Diaphragmatic Hernia.

World journal for pediatric & congenital heart surgery·2026

Same author

Autograft Enlargement After the Ross Procedure in Pediatric Patients: Somatic Growth or Pathologic Dilatation?

World journal for pediatric & congenital heart surgery·2026

Same author

Autograft reinforcement in the Ross procedure: A systematic review and patient-level meta-analysis.

The Journal of thoracic and cardiovascular surgery·2025

Same author

Surgical Approaches in Congenital Heart Disease With Congenital Diaphragmatic Hernia: A Multiinstitutional Analysis.

The Annals of thoracic surgery·2025

Same author

Improved Surgical Management of Complex Neonates With Heterotaxy Syndrome.

World journal for pediatric & congenital heart surgery·2025

Search research articles

Related Experiment Video

Updated: Jun 24, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

Stem cell therapy for ischemic heart disease: where are we?

Damien J LaPar¹, Irving L Kron, Zequan Yang

¹Department of Surgery, University of Virginia, Charlottesville, Virginia, USA.

Current Opinion in Organ Transplantation

|April 2, 2009

Summary

Stem cell therapy shows promise for ischemic heart disease, but results are mixed. Focus is shifting towards understanding stem cell function and optimizing their survival for better cardiac repair.

More Related Videos

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Related Experiment Videos

Last Updated: Jun 24, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Area of Science:

Cardiovascular Medicine
Regenerative Medicine
Stem Cell Biology

Background:

Ischemic heart disease (IHD) presents a significant therapeutic challenge due to scar tissue limiting cardiac function.
Stem cell transplantation is being investigated to replace scar tissue with viable myocardium, aiming to improve cardiac function and revascularization.
Recent advancements include induced pluripotent stem (iPS) cells, offering potential for revolutionary stem cell therapies.

Purpose of the Study:

To review the current state of stem cell therapy for ischemic heart disease.
To evaluate the effectiveness and underlying mechanisms of stem cell transplantation in cardiac repair.
To identify critical areas for future research to optimize stem cell therapy outcomes.

Main Methods:

Review of recent scientific literature on stem cell therapy for ischemic heart disease.
Analysis of findings from preclinical animal studies and emerging clinical trials.
Examination of stem cell behavior, including differentiation and paracrine effects.

Main Results:

Stem cell therapy for IHD has yielded inconclusive and often contradictory results.
The therapeutic benefit of stem cells appears to be primarily mediated by paracrine signaling rather than direct transdifferentiation into cardiomyocytes.
Factors within the systemic and local microenvironment significantly influence the fate and function of implanted stem cells.

Conclusions:

Despite controversial animal study results and unanswered questions, clinical trials are increasing.
Future research must address critical issues: optimizing the stem cell microenvironment for survival and differentiation, elucidating therapeutic mechanisms, and understanding stem cell fate.
Focusing on paracrine functions and controlled differentiation is crucial for advancing stem cell therapy in ischemic heart disease.